J Mult Scler Neuroimmunol > Volume 16(1); 2025 > Article
Journal of Multiple Sclerosis and Neuroimmunology 2025;16(1):26-32.
DOI: https://doi.org/10.59578/jmsni.2025.16.1.26-32    Published online June 30, 2025.
GM1, GD1a 항체 양성인 횡단성척수염과 병발한 급성운동축삭신경병의 임상적 증상과 예후
김아영1, 유홍근1, 전종현1, 권혁성2
1한양대학교 의과대학 신경과
2한양대학교 의과대학 한양대학교 구리병원 신경과
Clinical Manifestation and Prognosis of Overlapping Acute Motor Axonal Neuropathy and Acute Transverse Myelitis with Anti-GM1 and Anti-GD1a Antibodies: A Case Study
A Young Kim1, Hong Keun Yoo1, Jong Hyun Jeon1, Hyuk Sung Kwon2
1Department of Neurology, Hanyang University College of Medicine, Seoul, Korea
2Department of Neurology, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea
Correspondence:  Hyuk Sung Kwon, Tel: +82-31-560-2260, Fax: +82-31-560-2289, 
Email: kwonhs@hanyang.ac.kr
Received: 12 February 2025   • Revised: 11 March 2025   • Accepted: 7 April 2025
Abstract
Antibodies against GM1 and GD1a are closely associated with acute motor axonal neuropathy (AMAN). Patients simultaneously positive for both anti-GM1 and anti-GD1a antibodies are rare, and their clinical manifestations and prognosis remain unclear. Herein we report a 41-year-old male diagnosed with AMAN and acute transverse myelitis who was positive for immunoglobulin M anti-GM1, immunoglobulin G (IgG) anti-GM1, and IgG anti-GD1a antibodies. He experienced rapid progression of motor weakness to near quadriplegia within a few days, followed by substantial improvement over 6 months after initiation of steroid treatment, resulting in return of most activities of daily living.
Key Words: Antibodies against GM1, GD1a, Acute transverse myelitis, Guillain-Barre syndrome
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 15 View
  • 1 Download
Related articles


Editorial Office
Department of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine 102, Heukseok-ro, Dongjak-gu, Seoul 06973, Korea
Tel: +82-2-6299-3153   E-mail: jmsni@koreams.org                

Copyright © 2025 by Korean Society of Neuroimmunology.

Developed in M2PI